CDEX to showcase its ValiMed MVS at the ASHP Conference

Dec 1 2009

CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) will demonstrate its ValiMed™ MVS with new onsite data collection options at the ASHP Conference (Venetian Hotels & Sands Expo Center) in Las Vegas on December 7-9, 2009. Dennis Quaid, representing the Dennis Quaid Foundation, will provide a keynote address at the Conference. CDEX invites all those interested in medication safety to stop by Booth # 743 and learn how ValiMed MVS is saving lives in major hospitals today.

"The ASHP Mid-Year meeting presents an opportunity for CDEX to inform the Directors of Pharmacy from the nation's hospitals about the benefits of incorporating the ValiMed MVS into their pharmacy workflow," said Greg Firmbach, CDEX Senior VP. "ValiMed MVS is increasing overall patient safety as a final check in the prevention of human error in the compounding of high-risk medications and as the central validation point for the disposal of narcotics as part of a narcotic diversion prevention program."

Worldwide studies continue to show that human errors in the compounding of high-risk medications occur frequently and result in permanent harm to patients throughout the world and that the diversion of medical narcotics is a continuing problem. ValiMed MVS is a technological safety net that provides protection for patients, pharmacists and hospitals.

SOURCE: CDEX Inc.